Persistent URL of this record https://hdl.handle.net/1887/104639
Documents
-
- Download
- 1-s2.0-S1470204514700634-main
- Not Applicable (or Unknown)
- open access
In Collections
This item can be found in the following collections:
Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial
- All authors
- Judson, I.; Verweij, J.; Gelderblom, H.; Hartmann, J.T.; Schoffski, P.; Blay, J.Y.; Kerst, J.M.; Sufliarsky, J.; Whelan, J.; Hohenberger, P.; Krarup-Hansen, A.; Alcindor, T.; Marreaud, S.; Litiere, S.; Hermans, C.; Fisher, C.; Hogendoorn, P.C.W.; Tos, A.P. dei; Graaf, W.T.A. van der; European Org; Treatment Canc Soft Tissue Bone Sa
- Date
- 2014-04-30
- Journal
- The Lancet Oncology
- Volume
- 15
- Issue
- 4
- Pages
- 415 - 423